Safety and immunogenicity of COVID-19 mRNA vaccine SYS6006 evaluated in Phase 1 trial
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide. mRNA-based vaccines have emerged as a ...
Jun 30, 2023
0
46